Search by Drug Name or NDC
NDC 42291-0092-01 Benzonatate 200 mg/1 Details
Benzonatate 200 mg/1
Benzonatate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 42291-0092-01Last Updated: 04/07/2024
MedLinePlus Full Drug Details: Benzonatate
Product Information
| NDC | 42291-0092 |
|---|---|
| Product ID | 42291-092_0b501298-298f-ef70-e063-6294a90a941d |
| Associated GPIs | |
| GCN Sequence Number | 044168 |
| GCN Sequence Number Description | benzonatate CAPSULE 200 MG ORAL |
| HIC3 | H6C |
| HIC3 Description | ANTITUSSIVES, NON-OPIOID |
| GCN | 93007 |
| HICL Sequence Number | 001929 |
| HICL Sequence Number Description | BENZONATATE |
| Brand/Generic | Generic |
| Proprietary Name | Benzonatate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Benzonatate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZONATATE |
| Labeler Name | AvKARE |
| Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091133 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42291-0092-01 (42291009201)
| NDC Package Code | 42291-092-01 |
|---|---|
| Billing NDC | 42291009201 |
| Package | 100 CAPSULE in 1 BOTTLE (42291-092-01) |
| Marketing Start Date | 2023-11-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |